Ligand Pharmaceuticals
LGND
#4118
Rank
C$2.79 B
Marketcap
$145.36
Share price
0.33%
Change (1 day)
45.57%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.11

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.17. In 2022 the company made an earnings per share (EPS) of -$2.74 a decrease over its 2021 EPS that were of $4.79.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-177.13%
2022-$2.74-157.23%
2021$4.79-2571.43%
2020-$0.19-100.46%
2019$42.39353.48%
2018$9.351025%
2017$0.83-700%
2016-$0.14-100.87%
2015$16.011859.32%
2014$0.825.36%
2013$0.788.0704505322479E+18%
2012$0.0000000000-100%
2011$0.68-194.23%
2010-$0.72548.38%
2009-$0.11-98.7%
2008-$8.56-136.52%
2007$23.43-787.8%
2006-$3.41-14.58%
2005-$3.99-21.31%
2004-$5.07-55.15%
2003-$11.3081.33%
2002-$6.232.74%
2001-$6.07-45.93%
2000-$11.22-14.56%
1999-$13.13-45.52%
1998-$24.10-3.97%
1997-$25.09132.31%
1996-$10.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$19.59 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.50-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.85 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.52 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.58 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.52 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.50 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.09 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$19.51 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA